Clinical Trials Directory

Trials / Completed

CompletedNCT04254029

The Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni in Patients With Type II Diabetes Mellitus

Short Term Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni as add-on Therapy in a Population of Type II Diabetes Individuals

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
19 (estimated)
Sponsor
Yaounde Central Hospital · Other Government
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study was the evaluation of cardiovascular and renal benefits of moringa oleifera and stevia rebaudiana Bertoni in patients with type 2 diabetes mellitus before and after 8 weeks of add-on therapy.

Detailed description

The investigators performed a non-randomized single-arm clinical trial with a before and after design, carried out from November 2016 and May 2017. Intervention consisted of the administration of a daily consummation of 425 ml of drink containing the extracts of 1,38mg of leaves extracts of moringa oleifera and 23,46 mg of stevia rebaudiana Bertoni leaves extracts lasting 45 days. Before and after intervention, the following were done by the participants: bioelectrical impedance analysis (BIA), blood pressure measurements, fasting blood sugar, HbA1c, lipid profiles, liver function tests, kidney function tests, urinary excretion of albumin tests and full blood counts. These were followed by morphological workup including Electrocardiograms (ECGs), transthoracic heart ultrasounds and Ambulatory Blood Pressure Measurements (ABPM), also done before and after intervention. Clinical evaluation with fasting blood sugar control, blood pressure controls and urinary excretion albumin tests were done for safety purposes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMOROLSTEVER1The intervention consisted of a daily consummation of 425 ml of drink containing the extracts of 1,38mg of leaves extracts of moringa oleifera and 23,46 mg of stevia rebaudiana Bertoni leaves extracts lasting 45 days.

Timeline

Start date
2016-11-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2020-02-05
Last updated
2020-02-05

Locations

1 site across 1 country: Cameroon

Source: ClinicalTrials.gov record NCT04254029. Inclusion in this directory is not an endorsement.